Rosandra N. Kaplan, MD, pediatric oncologist and physician scientist at the National Cancer Institute, explains how understanding the tumor microevironment can fuel potential treatments.

Crystal Mackall, MD, shares how cell and gene therapies show promise for a potential breakthrough in osteosarcoma treatment.

Katherine Janeway, MD, MMSc, explains what precision oncology is, and how researchers are bridging gaps in precision treatment for osteosarcoma.

Medical oncologist and researcher Joelle Fenger, DVM, shares how this debilitating disease affects our canine friends and what new treatments are on the horizon.

Fernanda Arnaldez, MD, explains that small sample sets, disease complexity, and limited funding pose challenges in rare disease drug development, but the field is rapidly evolving, making her optimistic about the future.

OSI Grant Winner Daniel Vallera, PhD, explains a promising experimental osteosarcoma treatment intended to multiply the immune system’s “first responders” to combat osteosarcoma in dogs and humans.